HilleVax, Inc.
HLVX
$1.86
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.62M | 5.95M | 6.22M | 8.13M | 8.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.60M | 11.38M | 26.38M | 34.73M | 34.47M |
| Operating Income | -7.60M | -11.38M | -26.38M | -34.73M | -34.47M |
| Income Before Tax | -6.06M | -33.95M | -25.82M | -40.67M | -46.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.06M | -33.95M | -25.82M | -40.67M | -46.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.06M | -33.95M | -25.82M | -40.67M | -46.83M |
| EBIT | -7.60M | -11.38M | -26.38M | -34.73M | -34.47M |
| EBITDA | -7.35M | -10.90M | -25.90M | -34.26M | -34.02M |
| EPS Basic | -0.12 | -1.37 | -0.52 | -0.83 | -0.97 |
| Normalized Basic EPS | -0.09 | -0.19 | -0.33 | -0.43 | -0.42 |
| EPS Diluted | -0.12 | -1.37 | -0.52 | -0.83 | -0.97 |
| Normalized Diluted EPS | -0.09 | -0.19 | -0.33 | -0.43 | -0.42 |
| Average Basic Shares Outstanding | 49.98M | 49.58M | 49.38M | 49.18M | 48.46M |
| Average Diluted Shares Outstanding | 49.98M | 49.58M | 49.38M | 49.18M | 48.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |